| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |